Lung fibrosis is characterized by vascular leakage and myofibroblast recruitment, and both phenomena are mediated by lysophosphatidic acid (LPA) via its type-1 receptor (LPA1). Following lung damage, the accumulated myofibroblasts activate and secrete excessive extracellular matrix (ECM), and form fibrotic foci. Studies have shown that bone marrow-derived cells are an important source of myofibroblasts in the fibrotic organ. However, the type of cells in the bone marrow contributing predominantly to the myofibroblasts and the involvement of LPA-LPA1 signalling in this is yet unclear. Using a bleomycin-induced mouse lung-fibrosis model with an enhanced green fluorescent protein (EGFP) transgenic mouse bone marrow replacement, we first demons...
Pulmonary fibrosis (PF) is the result of chronic injury where fibroblasts become activated and secre...
Background: Mesenchymal stem cell (MSC) intervention has been associated with lung protection. We at...
This review highlights an emerging role for sphingosine 1-phosphate (S1P) and lysophosphatidic acid ...
acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibrobl...
Lysophosphatidic acid (LPA) signaling through one of its receptors, LPA1, contributes to both the de...
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by th...
<div><p>Idiopathic pulmonary fibrosis is a devastating disease with poor prognosis. The pathogenic r...
Mesenchymal stromal/stem cell (MSC) therapy has shown promise in experimental models of idiopathic p...
Mesenchymal stromal/stem cell (MSC) therapy has shown promise in experimental models of idiopathic p...
Idiopathic pulmonary fibrosis is a devastating disease with poor prognosis. The pathogenic role of t...
Abstract Background Bone marrow mesenchymal stem cells (BMSC) transfer has been attempted as a thera...
Pathological features of pulmonary fibrosis include accumulation of myofibroblasts and increased ext...
Abstract Background Lysophosphatidic acid (LPA) is a lipid mediator that acts through specific G pro...
International audienceThe development of fibrosis involves a multitude of events and molecules. Unti...
Myocardial fibrosis is a key pathologic feature of hypertrophic cardiomyopathy (HCM). However, the f...
Pulmonary fibrosis (PF) is the result of chronic injury where fibroblasts become activated and secre...
Background: Mesenchymal stem cell (MSC) intervention has been associated with lung protection. We at...
This review highlights an emerging role for sphingosine 1-phosphate (S1P) and lysophosphatidic acid ...
acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibrobl...
Lysophosphatidic acid (LPA) signaling through one of its receptors, LPA1, contributes to both the de...
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by th...
<div><p>Idiopathic pulmonary fibrosis is a devastating disease with poor prognosis. The pathogenic r...
Mesenchymal stromal/stem cell (MSC) therapy has shown promise in experimental models of idiopathic p...
Mesenchymal stromal/stem cell (MSC) therapy has shown promise in experimental models of idiopathic p...
Idiopathic pulmonary fibrosis is a devastating disease with poor prognosis. The pathogenic role of t...
Abstract Background Bone marrow mesenchymal stem cells (BMSC) transfer has been attempted as a thera...
Pathological features of pulmonary fibrosis include accumulation of myofibroblasts and increased ext...
Abstract Background Lysophosphatidic acid (LPA) is a lipid mediator that acts through specific G pro...
International audienceThe development of fibrosis involves a multitude of events and molecules. Unti...
Myocardial fibrosis is a key pathologic feature of hypertrophic cardiomyopathy (HCM). However, the f...
Pulmonary fibrosis (PF) is the result of chronic injury where fibroblasts become activated and secre...
Background: Mesenchymal stem cell (MSC) intervention has been associated with lung protection. We at...
This review highlights an emerging role for sphingosine 1-phosphate (S1P) and lysophosphatidic acid ...